Benzinga | Aug 5, 2020 04:59PM EDT

ADMA Biologics Q2 EPS $(0.23) Misses $(0.16) Estimate, Sales $7.79M Miss $10.57M Estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.16) by 43.75 percent. This is a 8 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $7.79 million which missed the analyst consensus estimate of $10.57 million by 26.33 percent. This is a 18.69 percent increase over sales of $6.56 million the same period last year.